Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the management of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://nelsonoqoa594413.blog-eye.com/39300661/retaglutide-a-promising-glp-1-receptor-agonist